Related Experiment Videos
Vascular renin-angiotensin-system, endothelial function and atherosclerosis?
Basic Research in Cardiology
|January 1, 1994
Summary
Sustained activation of the renin-angiotensin system increases heart attack risk. Blocking this system, particularly with angiotensin converting enzyme inhibitors, may protect against heart attacks and atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Biochemistry
Background:
- The renin-angiotensin system (RAS) plays a crucial role in cardiovascular regulation.
- Sustained RAS activation is linked to an increased risk of myocardial infarction (MI).
- Nitric oxide (NO) has protective antiatherogenic effects on the vasculature.
Purpose of the Study:
- To investigate the proatherogenic effects of activated RAS.
- To explore the role of nitric oxide (NO) downregulation in RAS-mediated atherogenesis.
- To evaluate the potential of RAS blockade in preventing atherosclerosis and MI.
Main Methods:
- Review of clinical observations linking RAS activation to MI risk.
- Analysis of experimental evidence on RAS, NO, and atherosclerosis.
- Examination of the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor type-1 (AT1) antagonists.
Main Results:
- Activated RAS, particularly via angiotensin II, downregulates endothelial nitric oxide (NO) releasability.
- Hypertension-induced arterial distension upregulates local RAS, further reducing NO.
- RAS blockade (ACE inhibitors, AT1 antagonists) normalizes NO releasability and attenuates experimental atherosclerosis.
Conclusions:
- Activated RAS contributes to atheroma development by reducing NO bioavailability.
- Chronic RAS blockade demonstrates antiatherogenic potential by restoring NO function.
- Further studies are needed to confirm the antiatherogenic benefits of RAS blockade in humans.